Tetrahydrocortisol
Appearance
Names | |
---|---|
IUPAC name
3α,11β,17,21-Tetrahydroxy-5β-pregnan-20-one
| |
Systematic IUPAC name
2-Hydroxy-1-(1R,3aS,3bS,5aR,7R,9aS,9bS,10S,11aS)-1,7,10-trihydroxy-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]ethan-1-one | |
Other names
Urocortisol; 3α,5β-Tetrahydrocortisol; 3α,5β-Cortisol
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.000.146 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C21H34O5 | |
Molar mass | 366.49 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Tetrahydrocortisol, or urocortisol, also known as 3α,11β,17α,21-tetrahydroxy-5β-pregnan-20-one, is a steroid and an inactive metabolite of cortisol.[1]
Tetrahydrocortisol is a neurosteroid and has been found to act as a negative allosteric modulator of the GABAA receptor, similarly to pregnenolone sulfate.[2][3][4]
See also
[edit]References
[edit]- ^ Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 915–. ISBN 978-1-60913-345-0.
- ^ Nikolaou N, Hodson L, Tomlinson JW (March 2021). "The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies". J Steroid Biochem Mol Biol. 207: 105808. doi:10.1016/j.jsbmb.2021.105808. PMID 33418075. S2CID 230716310.
- ^ Chen M, Penning TM (May 2014). "5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1)". Steroids. 83: 17–26. doi:10.1016/j.steroids.2014.01.013. PMC 3971473. PMID 24513054.
- ^ Penland SN, Morrow AL (December 2004). "3alpha,5beta-Reduced cortisol exhibits antagonist properties on cerebral cortical GABA(A) receptors". Eur J Pharmacol. 506 (2): 129–32. doi:10.1016/j.ejphar.2004.11.007. PMID 15588732.